Water-soluble thalidomine derivatives

Details for Australian Patent Application No. 2004224271 (hide)

Owner Tian Jin Hemay Bio-Tech Co. Ltd

Inventors Zhang, Hesheng

Agent Davies Collison Cave

Pub. Number AU-B-2004224271

PCT Pub. Number WO2004/085422

Priority 03120994.7 27.03.03 CN

Filing date 4 March 2004

Wipo publication date 7 October 2004

Acceptance publication date 18 February 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/454 (2006.01)

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/085422 Priority application(s): WO2004/085422

18 February 2010 Application Accepted

  Published as AU-B-2004224271

17 June 2010 Standard Patent Sealed

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004224277-Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor

2004224268-Method for bundling an object, and corresponding clamping block